Hutch News
Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
September 25, 2023
The Dos and Don’ts of designing peptide HLA-I single-chain trimers
From the Strong Lab, Basic Sciences and Vaccine and Infectious Disease Divisions
Award will fund research into new metastatic prostate cancer therapies
Physician-scientist Dr. John Lee and his team will use $750K Kleberg Foundation grant to pursue new treatments, including immunotherapy
Eight promising projects win Evergreen Fund grants to promote commercialization of research
A dozen scientists to receive up to $200K from 3-year-old Fred Hutch program
Unlocking a new path for cystine-dense peptides
From the Olson Lab, Clinical Research Division and the Strong Lab, Basic Sciences and Vaccine and Infectious Disease Divisions
New technological platform opens unexplored world of tiny proteins
'Cystine-dense peptides' largely untapped source of new therapeutics for tough diseases
‘Outrageous experience’: Researchers recall pioneering experiments on Soviet space station
Drs. Roland Strong and Barry Stoddard were part of the first U.S. group to launch scientific experiments 25 years ago on the Soviet space station
Strong team: Stopping the invasion of the iron snatchers
Findings may help foil anthrax and common bacteria's strategies for evading the body's defenses
Vaccine's $40 million boost
Bill & Melinda Gates Foundation provides funding to accelerate HIV-vaccine development
The iron fist of the immune system
Study shows protein Lcn2 prevents intestinal infection by depriving bacteria of essential iron